Strs Ohio Editas Medicine, Inc. Transaction History

Strs Ohio

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$26.55 - $40.57 $451,350 - $689,690	-17,000 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$39.27 - $72.94 $428,043 - $795,046	10,900 Added 178.69%	17,000 $698,000
Q4 2020 Jan 25, 2021	BUY	$27.07 - $84.35 $138,057 - $430,185	5,100 Added 510.0%	6,100 $427,000
Q2 2020 Jul 23, 2020	BUY	$18.5 - $34.34 $18,500 - $34,340	1,000 New	1,000 $29,000

244

56.8M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $87.3M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.